PL357517A1 - Białko chimeryczne, sekwencja, konstrukt, komórkaroślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina, zastosowanie transgenicznej rośliny i chimerycznego białka - Google Patents

Białko chimeryczne, sekwencja, konstrukt, komórkaroślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina, zastosowanie transgenicznej rośliny i chimerycznego białka

Info

Publication number
PL357517A1
PL357517A1 PL02357517A PL35751702A PL357517A1 PL 357517 A1 PL357517 A1 PL 357517A1 PL 02357517 A PL02357517 A PL 02357517A PL 35751702 A PL35751702 A PL 35751702A PL 357517 A1 PL357517 A1 PL 357517A1
Authority
PL
Poland
Prior art keywords
transgenic plant
chimeric protein
application
sequence
construction
Prior art date
Application number
PL02357517A
Other languages
English (en)
Other versions
PL201419B1 (pl
Inventor
Andrzej B. Legocki
Katarzyna Miedzińska
Magdalena Czaplińska
Anna Modelska
Tomasz Pniewski
Andrzej Płucienniczak
Małgorzata Kęsik
Anna Porębska
Halina Wędrychowicz
Juliusz Mieszczanek
Luiza Jedlina-Panasiuk
Original Assignee
Instytut Chemii Bioorganicznej Pan
Instytut Biotechnologii i Antybiotyków
Instytut Parazytologii im.Witolda Stefańskiego PAN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Chemii Bioorganicznej Pan, Instytut Biotechnologii i Antybiotyków, Instytut Parazytologii im.Witolda Stefańskiego PAN filed Critical Instytut Chemii Bioorganicznej Pan
Priority to PL357517A priority Critical patent/PL201419B1/pl
Priority to AT03786456T priority patent/ATE362988T1/de
Priority to PCT/PL2003/000135 priority patent/WO2004050883A2/en
Priority to ES03786456T priority patent/ES2288223T3/es
Priority to EP03786456A priority patent/EP1613752B1/en
Priority to NZ540582A priority patent/NZ540582A/en
Priority to DK03786456T priority patent/DK1613752T3/da
Priority to AU2003295293A priority patent/AU2003295293B2/en
Priority to DE60314017T priority patent/DE60314017T2/de
Publication of PL357517A1 publication Critical patent/PL357517A1/pl
Publication of PL201419B1 publication Critical patent/PL201419B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/641—Cysteine endopeptidases (3.4.22)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
PL357517A 2002-12-04 2002-12-04 Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina PL201419B1 (pl)

Priority Applications (9)

Application Number Priority Date Filing Date Title
PL357517A PL201419B1 (pl) 2002-12-04 2002-12-04 Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina
AT03786456T ATE362988T1 (de) 2002-12-04 2003-12-04 Chimaeres protein enthaltend die cystein protease aus dem grossen leberegel fusioniert an das hepatitis b core protein oder ubiquitin; pflanzen,welches dieses protein exprimieren, sowie deren verwendung als vakzine
PCT/PL2003/000135 WO2004050883A2 (en) 2002-12-04 2003-12-04 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
ES03786456T ES2288223T3 (es) 2002-12-04 2003-12-04 Proteina quimerica que contiene proteinasa cisteinica de fasciola hepatica fusionada con la proteina del nucleo del virus de la hepatitis b o de la ubiquitina; plantas expresando dicha proteina; y su utilizacion como vacuna.
EP03786456A EP1613752B1 (en) 2002-12-04 2003-12-04 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
NZ540582A NZ540582A (en) 2002-12-04 2003-12-04 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis B core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
DK03786456T DK1613752T3 (da) 2002-12-04 2003-12-04 Molekyle af nukleinsyre, plantecelle, fremgangsmåde til fremstilling af kimærisk protein, fremgangsmåde til fremstilling af transgen plante, transgen plante, anvendelse af transgen plante, farmaceutisk komposition, vaccine mod leverikten
AU2003295293A AU2003295293B2 (en) 2002-12-04 2003-12-04 Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis B core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
DE60314017T DE60314017T2 (de) 2002-12-04 2003-12-04 Chimaeres protein enthaltend die cystein protease aus dem grossen leberegel fusioniert an das hepatitis b core protein oder ubiquitin; pflanzen, welches dieses protein exprimieren, sowie deren verwendung als vakzine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL357517A PL201419B1 (pl) 2002-12-04 2002-12-04 Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina

Publications (2)

Publication Number Publication Date
PL357517A1 true PL357517A1 (pl) 2004-06-14
PL201419B1 PL201419B1 (pl) 2009-04-30

Family

ID=32464755

Family Applications (1)

Application Number Title Priority Date Filing Date
PL357517A PL201419B1 (pl) 2002-12-04 2002-12-04 Białko chimeryczne, sekwencja, konstrukt, komórka roślinna, sposób otrzymywania białka chimerycznego, transgenicznej rośliny, transgeniczna roślina

Country Status (9)

Country Link
EP (1) EP1613752B1 (pl)
AT (1) ATE362988T1 (pl)
AU (1) AU2003295293B2 (pl)
DE (1) DE60314017T2 (pl)
DK (1) DK1613752T3 (pl)
ES (1) ES2288223T3 (pl)
NZ (1) NZ540582A (pl)
PL (1) PL201419B1 (pl)
WO (1) WO2004050883A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL196114B1 (pl) * 2002-12-31 2007-12-31 Inst Biotechnologii I Antybiot Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt
EP1774001B1 (en) * 2004-06-25 2012-08-22 Altor BioScience Corporation Mammalian Tissue Factor obtained from plants and applications of the same
US9610335B2 (en) * 2009-12-10 2017-04-04 Escola Superior Agrária De Coimbra Immunogens, compositions and uses thereof, method for preparing same
WO2014124047A1 (en) * 2013-02-06 2014-08-14 Academia Sinica Antimicrobial peptides derived from hepatitis b virus core protein arginine-rich domain
CA3024873A1 (en) 2016-05-27 2017-11-30 Chiaho Shih Modified antimicrobial peptide derived from an arginine-rich domain

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006658A1 (en) * 1988-01-13 1989-07-27 The University Of North Carolina At Chapel Hill Immunogenic peptides
US6623735B1 (en) * 1992-10-21 2003-09-23 John P. Dalton Vaccine containing a thiol protease
WO1994017820A1 (en) * 1993-02-05 1994-08-18 Daratech Pty. Ltd. Polypeptides obtainable from species of fasciola, and vaccines, methods of treatment and dna sequences of the same
GB9312324D0 (en) * 1993-06-15 1993-07-28 Pitman Moore Inc Vaccine
US6319503B1 (en) * 1998-02-19 2001-11-20 Proteinix Company Heat shock fusion-based vaccine system

Also Published As

Publication number Publication date
DE60314017D1 (de) 2007-07-05
WO2004050883A2 (en) 2004-06-17
WO2004050883A3 (en) 2004-11-04
DE60314017T2 (de) 2008-01-17
NZ540582A (en) 2008-05-30
ES2288223T3 (es) 2008-01-01
DK1613752T3 (da) 2007-09-10
PL201419B1 (pl) 2009-04-30
ATE362988T1 (de) 2007-06-15
AU2003295293B2 (en) 2009-12-03
EP1613752B1 (en) 2007-05-23
EP1613752A2 (en) 2006-01-11
AU2003295293A1 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
WO2008057529A3 (en) Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
WO2008057235A3 (en) Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes
DE60238471D1 (de) Proteosom-liposaccharid-vakzine-adjuvans
TW200626173A (en) IL-23p40 specific immunoglobulin derived proteins, compositions, epitopes, methods and uses
WO2008002663A3 (en) Immunogenic protein constructs
WO2001095933A3 (en) Immunization through oral administration of a vaccine with an edible product
AU2003277282A8 (en) The isolation, culture, and use of marine copepods in aquaculture
NZ596501A (en) Casb7439 constructs
BRPI0410861A (pt) métodos e composições para a produção de aminoácidos
Kęsik et al. Inclusion bodies from recombinant bacteria as a novel system for delivery of vaccine antigen by the oral route
WO2006124451A3 (en) Anti-il-13 antibodies, compositions, methods and uses
DE60110047D1 (de) Zahn-vorläuferzelle und methode für deren herstellung
EP1438066A4 (en) IMMUNOGENIC COMPOSITIONS OF ENTIRE CELLS OF REACTIVE BACTERIA
WO2007016598A3 (en) Influenza vaccine compositions and methods of use thereof
WO2004050883A3 (en) Chimaeric protein containing cysteine protease of liver fluke fused to hepatitis b core protein or ubiquitin, plants expressing said protein, and uses thereof as vaccine
NO20053328L (no) Immunisering av fisk med uttrykte proteiner i planteceller.
AU2003221579A1 (en) Encapsulated cells to elicit immune response
WO2004050692A3 (en) Fusion of the e2 protein of csfv with kdel , vts and/or ubiquitin for expression in transgenic plants for vaccine production
WO2005009397A3 (en) Human lymphocyte vaccine adjuvant
AR042237A1 (es) Obtencion de estructuras cocleares, composiciones vacunales, adyuvantes y sus intermediarios
PL358081A1 (pl) Ciałka inkluzyjne jako antygeny do doustnej immunizacji zwierząt
EP0745386A4 (en) SECRETORIC RECOMBINANT BCG VACCINE AGAINST AIDS
DK1553979T3 (da) IHNV-G-fusionsprotein til immunistimulering
DE69637435D1 (de) Saponin-zusammensetzungen und deren verwendung

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20131204